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Abstract
Purpose—To investigate associations of sociodemographic factors—race/ethnicity, 
neighborhood socioeconomic status (SES), and health insurance—with survival for adolescent and 
young adults (AYAs) with invasive cancer.
Methods—Data on 80,855 AYAs with invasive cancer diagnosed in California 2001–2011 were 
obtained from the California Cancer Registry. We used multivariable Cox proportional hazards 
regression to estimate overall survival.
Results—Associations of public or no insurance with greater risk of death were observed for 11 
of 12 AYA cancers examined. Compared to Whites, Blacks experienced greater risk of death, 
regardless of age or insurance, while greater risk of death among Hispanics and Asians was more 
apparent for younger AYAs and for those with private/military insurance. More pronounced 
neighborhood SES disparities in survival were observed among AYAs with private/military 
insurance, especially among younger AYAs.
Conclusions—Lacking or having public insurance was consistently associated with higher 
morality, while disparities according to race/ethnicity and neighborhood SES were greater among 
AYAs with private/military insurance. While health insurance coverage associates with survival, 
remaining racial/ethnic and socioeconomic disparities among AYAs with cancer suggest social 
factors also need consideration in intervention and policy development.
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1. Background
Cancer is the most frequent cause of disease-related death among adolescents and young 
adults (AYAs) 15–39 years of age at diagnosis [1]. While cancer survival among AYAs with 
many types of cancer is good, above 80%, AYAs have not experienced the same 
improvements in relative survival as children and older adults for cancers common among 
AYAs [2, 3]. In addition, AYAs, historically, have had the highest uninsurance rates 
compared with children and older adults [4–6]. Furthermore, disparities in cancer survival 
by race/ethnicity and neighborhood socioeconomic status (SES)—previously well-
documented only among older adults—have recently been reported among AYAs [7–10].
There is evidence that racial/ethnic disparities in cancer survival for some cancer sites may 
be mediated by access to health care or neighborhood SES [7, 8, 10]. It is well-documented 
that, compared to non-Hispanic White AYAs, Hispanic and Black AYAs are more likely to 
reside in lower SES neighborhoods [10] and are more likely to be uninsured or have public 
insurance [11, 12]. Furthermore, each of these sociodemographic factors (i.e., minority race/
ethnicity, lower neighborhood SES, and public or no insurance at diagnosis) have been 
associated with later-stage at diagnosis [11–13], undertreatment [7, 11], and greater risk of 
death among AYAs [7–11, 13, 14]. The few studies that have considered the independent 
associations of all three factors with cancer survival suggest that these associations remain in 
multivariable analyses, but differences exist by cancer site [8–10, 14]. Of note, however, no 
studies have considered the joint relationship of race/ethnicity, neighborhood SES, and 
health insurance type with survival among AYAs.
Therefore, we analyzed patient data from the California Cancer Registry to determine joint 
associations of sociodemographic factors with overall survival for all invasive cancers and 
the twelve most common cancers among AYAs. In addition, given that survival among AYAs 
with cancer can differ markedly from that of younger or older patients [15], we hypothesized 
that associations of sociodemographic variables with survival would differ by age, so we 
stratified analyses into three AYA age subgroups. Identifying sociodemographic subgroups 




The California Cancer Registry (CCR) is part of the National Cancer Institute’s (NCI’s) 
Surveillance, Epidemiology and End Results (SEER) Program and includes all cancer 
diagnoses in California since 1988 [16–19] with annual patient follow-up for vital status. We 
obtained information about California residents diagnosed with first-primary, invasive cancer 
from January 1, 2001 (first year of sufficient data regarding insurance type at diagnosis) 
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through December 31, 2011 at 15–39 years of age. For each case, we obtained cancer 
registry information routinely abstracted from the medical record (Table 1); race/ethnicity, 
age at diagnosis, marital status, year of diagnosis, sex, and SEER summary stage at 
diagnosis; in addition to vital status as of December 31, 2012. Categories for age at 
diagnosis (15–24, 25–34, and 35–39) utilize similar cut-points as standard reporting by 
cancer registries and optimize the distribution of cases among categories. Vital status is 
routinely determined by the CCR through hospital follow-up [8, 9] and database linkages.
Individual primary cancer sites were defined with Primary Site and ICD-O-3 Histology 
codes according to the SEER AYA Site Recode, based on the AYA classification suggested 
by Barr et al. [20] and updated based on histology changes in the WHO Hematopoietic/
Lymphoid tissue book (AYA Site Recode ICD-O-3/WHO 2008). Primary sites not 
designated in the AYA recode were defined via Primary Site and ICD-O-3 Histology codes 
listed in the SEER Site recode (Site Recode ICD-O-3/WHO 2008).
Of the 81,954 AYAs diagnosed with histologically confirmed, first primary invasive cancer, 
we excluded those cases diagnosed by autopsy or death certificate and other cases with no 
survival time, due to missing dates (n=471, 0.57%). Patients with non-Hodgkin lymphoma 
or Kaposi sarcoma and HIV or who died of AIDS were also excluded (n=628, 0.77%) to 
eliminate the direct effects of the AIDS epidemic. The final study population included 
80,855 AYAs.
2.2 Sociodemographic variables
Sociodemographic variables recorded in the CCR include race/ethnicity, SES, and insurance 
type. Race/ethnicity was classified as non-Hispanic White, non-Hispanic Black, Hispanic, 
non-Hispanic Asian/Pacific Islander (PI), and other/unknown; and are hereafter referred to 
as White, Black, Hispanic, Asian/PI, and other; respectively [21].
Neighborhood SES is a previously described index that incorporates 2000 U.S. Census (for 
cases diagnosed through 2005) [22] and 2006–2010 American Community Survey data (for 
cases diagnosed 2006 forward) [23] on education, occupation, unemployment, household 
income, poverty, rent, and home values. Index scores are grouped into quintiles from highest 
to lowest SES index value based on the distribution of scores across census tracts in 
California [22, 23]. Residential addresses of cancer cases were geocoded by the CCR to the 
census tract level, allowing assignment of a neighborhood SES index value to each case.
Health insurance, defined as the primary source of payment at diagnosis or initial treatment, 
is routinely abstracted for patients diagnosed since 2001. As in previous AYA studies [11, 
13, 24, 25], insurance type was categorized as private/military (private insurance managed 
care, health maintenance organization, or preferred provider organization; private Insurance 
Fee-for-Service; military; Veterans Affairs; Tricare; or insurance, not otherwise specified), 
public/none (Medicaid, Medicare, Indian/Public Health Service, county funded not 
otherwise specified, not insured, not insured self-pay), and unknown. Consistent with prior 
observations that the small percentage of AYA cancer patients who were uninsured likely 
reflect retroactive enrollment in Medicaid at the time of cancer diagnosis [8, 13, 14], we 
considered publicly insured and uninsured together in the survival analyses.
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Survival analyses were conducted using SAS software version 9.3 (SAS Institute Inc., Cary, 
North Carolina). Frequencies and column percentage by race/ethnicity were determined 
according to sociodemographic and clinical characteristics and select cancer sites. Bivariate 
chi-square tests of association were performed for each covariate among the total population 
and within each racial/ethnic group. Survival time was calculated in days from the date of 
diagnosis to date of death, date of last follow-up, or study end date (December 31, 2012), 
whichever came first.
Multivariable models for specific cancer sites were adjusted for marital status, age at 
diagnosis, sex, and SEER summary stage in addition to sociodemographic variables of 
interest. We assessed the proportional hazards assumption for all models by examining 
survival curves and by statistical testing of the correlation between weighted Shoenfeld 
residuals and logarithmically transformed survival time. Stage at diagnosis violated 
proportional hazards and was thus included as a stratifying variable in all models, which 
allows for differing baseline hazards but precludes report of HRs for this variable [26].
We examined associations of race/ethnicity, neighborhood SES and insurance type with 
overall survival using Cox multivariable proportional hazards regression to estimate hazard 
ratios (HRs) and 95% confidence intervals (CIs) for three AYA age groups (15–24 years of 
age, 25–34 years of age, and 35–39 years of age) for ease of interpretation. Multivariable 
models for each age group were additionally adjusted for marital status, year of diagnosis, 
sex, and SEER summary stage. Statistically significant main effects were evaluated at 
p<0.05. Within age-group specific models, we tested for interactions among 
sociodemographic variables of interest (race/ethnicity, neighborhood SES, and insurance 
type) and found two significant interactions (p<0.10): race/ethnicity an.d insurance type and 
neighborhood SES and insurance type. Thus, these interaction terms were included in 
models for every age group (p-values for each interaction term in footnote to Table 3).
3. Results
Of the 80,855 AYAs in our study, most are White (46.8%), followed by 33.5% Hispanic, 
11.8% Asian/PI, 5.3% Black, and 2.5% other race/ethnicity. Nearly one-third of White 
(29.3%) and Asian/PI (29.4%) AYAs reside in the highest SES neighborhoods, while 26.8% 
of Black AYAs and 34.6% of Hispanic AYAs reside in lowest SES neighborhoods (Table 1). 
Thirty-seven (36.8) percent of Black AYAs and 40.7% of Hispanic AYAs have no or public 
insurance, proportions that were much higher than that of White (15.0%) or Asian/PI 
(17.6%) AYAs. Breast cancer is the most frequently diagnosed invasive cancer among AYAs 
in California (14.5%), followed by thyroid cancer (12.7%), melanoma (9.8%), testicular 
cancer (9.1%), non-Hodgkin lymphoma (5.8%), Hodgkin lymphoma (5.8%), leukemia 
(5.3%), cervical cancer and sarcoma (each 5.2%), central nervous system cancers (4.1%), 
and ovarian cancer (2.3%).
Table 2 presents associations of race/ethnicity, neighborhood SES, and insurance type with 
overall survival by cancer site/type. In models adjusted for neighborhood SES and insurance 
type, Black AYAs with breast cancer, testicular cancer, Hodgkin lymphoma, leukemia, and 
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cervical cancer have greater risk of death than White AYAs with these cancers. In addition, 
Hispanic AYAs with testicular cancer, non-Hodgkin lymphoma, and leukemia also have 
greater risk of death than White AYAs with these cancers. Independent neighborhood SES 
disparities are present for half of the cancer sites examined (breast cancer, melanoma, non-
Hodgkin lymphoma, Hodgkin lymphoma, leukemia, sarcoma and colorectal cancer). For 
every cancer site except ovarian cancer, AYAs with no or public insurance at diagnosis had 
greater risk of death compared to AYAs with private/military insurance, with HR’s ranging 
from 1.16 (95% CI 1.04–1.29) for leukemia to 2.61 (95% CI 2.13–3.20) for melanoma.
Table 3 presents multivariable models of overall survival after invasive cancer separately for 
three AYA age groups. For each age group, no or public insurance is associated with greater 
risk of death compared to private/military insurance (HR for 15–24 years, 1.50 [95% CI, 
1.38–1.64]; HR for 25–34 years, 1.76 [95% CI 1.66–1.87]; HR for 35–39 years, 1.52 [95% 
CI 1.44–1.62]; data not shown in table). Of note, however, within each age group, racial/
ethnic disparities in survival differ by insurance type and are generally more persistent 
among groups under age 35 and those with private/military insurance. Among AYAs 15–24 
years of age; Black, Hispanic, and Asian/PI AYAs with both private/military and no or 
public insurance have greater risk of death than White AYAs, although the higher HR for 
Hispanics compared to Whites with no or public insurance is non-significant. Only for Black 
AYAs does this survival disparity compared to non-Hispanic White AYAs persist for each 
insurance type within each age group. For Hispanics 25–34 years of age, a survival disparity 
is only apparent for those with private/military insurance (HR, 1.26; 95% CI, 1.16–1.38). 
Hispanics 35–39 years of age do not have greater risk of death compared to Whites, 
regardless of insurance type, and in fact, Hispanics in this age group with public or no 
insurance actually have lower risk of death compared to Whites (HR, 0.84; 95% CI, 0.76–
0.93). Greater risk of death for Asian/PI AYAs with public or no insurance is borderline 
(present, but non-significant) for those 25–34 years of age (HR, 1.14; 95% CI, 0.98–1.33) 
and undetected for those 35–39 years of age (HR, 1.02; 95% CI, 0.87–1.18) while greater 
risk of death for Asian/PI AYAs with private/military insurance is present in each AYA age 
group.
Survival disparities according to neighborhood SES are more apparent with increasing age 
and among AYAs with private/military insurance (Table 3). There are no associations 
between neighborhood SES and survival for AYAs 15–24 years of age with public insurance. 
However, among AYAs 15–24 years of age with private insurance, those residing in lower 
SES neighborhoods have greater risk of death than those in the highest SES neighborhoods. 
Among AYAs 25–34 years of age, those with public insurance residing in lower-middle or 
the lowest SES neighborhoods have greater risk of death than AYAs in the highest SES 
neighborhoods (the HR for lowest compared to highest SES neighborhood is non-
significant), while, among those with private/military insurance, AYAs residing in the three 
lowest SES neighborhoods have greater risk of death than those in the highest SES 
neighborhoods. For AYAs 35–39 years of age, those with public insurance residing in the 
lowest versus highest SES neighborhoods have greater risk of death, but among AYAs with 
private/military insurance, those residing in the four lowest SES neighborhoods have greater 
risk of death than those in the highest SES neighborhoods, with HR’s ranging from 1.19 
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(95% CI, 1.09–1.31) for higher-middle to 1.71 (95% CI, 1.52–1.92) for lowest neighborhood 
SES.
4. Discussion
In this population-based study of AYAs with invasive cancer, we found that lacking 
insurance or having public insurance was consistently associated with greater risk of death 
for AYAs of all ages and with nearly all types of cancer. While we observed persistent 
survival disparities for Black AYAs, compared to White AYAs, regardless of age group or 
insurance type, disparities among Hispanic and Asian AYAs were more pronounced for 
younger age groups and for those with private/military insurance. We also observed more 
pronounced neighborhood SES disparities in survival among AYAs with private/military 
insurance, compared to those with nor or public insurance, especially among younger AYAs.
Expanding upon the findings of a prior study that reported greater risk of death for AYAs 
with no or public insurance [13], our results indicate these associations persist when 
additional, potentially confounding, sociodemographic factors (i.e. marital status, race/
ethnicity, and neighborhood SES) are considered and is apparent for each of the eleven most 
common AYA cancers. Given that the small percentage of AYA cancer patients who were 
uninsured likely reflect retroactive enrollment in Medicaid at the time of cancer diagnosis [8, 
13, 14], we considered publicly insured and uninsured together in the survival analyses. A 
number of factors related to healthcare access may mediate associations of no or public 
insurance with survival; including stage at diagnosis, delays in treatment receipt, details of 
treatment receipt and completion, Medicaid provider restrictions, or availability of 
information and support services among patients and survivors. While we considered stage 
at diagnosis, we were unable to include other access-related factors due to the broad scope 
of the study and/or lack of additional patient-level data. The importance of these potential 
mediators, however, has been indicated by recent research. AYAs with no insurance are more 
likely to experience delays in treatment initiation [24] and less likely to receive definitive 
treatment [11], and estimates for treatment non-adherence among AYAs with cancer range 
from 27% to 60% [27]. In addition, the quality of cancer-care received at safety-net hospitals 
may not be comparable to other hospitals [28]. Furthermore, we have shown that AYA 
survivors without insurance more frequently report cancer-related information needs [29], 
and are less likely to receive cancer-related medical care in survivorship compared to 
survivors with insurance [5]—factors that may put uninsured AYA survivors at greater risk 
for long-term cancer-related complications. Indeed, we observed that the six AYA cancer 
sites with the highest relative survival rates (thyroid, testis, melanoma, breast, Hodgkin’s 
lymphoma, and non-Hodgkin lymphoma) [30] have the strongest associations between 
health insurance and survival, suggesting that insurance likely influences not only the initial 
diagnosis and treatment, as found previously [11, 12], but what happens beyond the initial 
treatment period.
Greater risk of death among AYAs lacking or having public insurance is particularly 
alarming because, compared to children and older adults, AYAs have historically had the 
highest uninsurance rates [11], Since 2010, a provision of the Patient Protection and 
Affordable Care Act (ACA) allows young adults to remain on their parents’ insurance plan 
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until they are 26 years of age (rather than 23 years of age). Consequently, the percent of 
young adults 19–25 years of age insured increased from around 65% to greater than 72% 
between 2010 and 2011 [4]. Mandated coverage and the insurance marketplace, components 
of the ACA that took effect in 2014, have further increased insurance coverage among AYAs 
[31]. Our results from 2001–2011, then, suggest that increases in the number of AYAs 
insured at the time of cancer diagnosis will have a positive impact on survival, but whether 
this is the case cannot yet be determined. The racial/ethnic and neighborhood SES 
disparities in survival we observe among AYAs with private/military insurance, however, 
suggest that increasing insurance coverage alone will not alleviate all outcome disparities.
Insurance coverage is often presented as a key mediator of racial/ethnic and SES disparities 
in survival, and recent reports, including ours, of associations between no or public 
insurance and cancer outcomes among AYAs after adjustment for race/ethnicity and SES 
support this view [11, 13, 32–34]. Our results confirm the importance of insurance coverage, 
but also indicate that substantial racial/ethnic and neighborhood SES disparities remain even 
among the privately insured. Our findings are consistent with recent studies that found 
greater financial burden associated with a cancer diagnosis for those that are relatively 
young, of non-White race/ethnicity, or have lower SES, regardless of insurance status [35–
42]. For those with private insurance, financial burden can result from out-of-pocket costs 
associated with, for example, co-payments, co-insurance, deductibles, and out-of-network 
costs that may determine treatment plans, treatment completion, and overall well-being [36, 
41–43]. For example, in studies of individuals of all ages, African Americans and residents 
of low SES neighborhoods are overall less likely to receive standard medical treatment 
compared to Whites, even when they have the same insurance coverage [28], a disparity 
noted by other reports specific to cancer care [44, 45]. Financial burden among minority and 
low SES groups, even if privately insured, may thus be a key contributor to racial/ethnic and 
SES disparities in treatment and survival. The issue of financial burden will likely increase 
in importance as ACA requirements result in cost-shifting on the part of insurance providers 
and cancer care costs continue to rise [46]. Further research should aim to determine the 
degree to which financial burden directly contributes to independent racial/ethnic and 
neighborhood SES disparities in treatment receipt and survival.
There are also likely other factors influencing the racial/ethnic and neighborhood SES 
disparities in survival that we observed, including treatment receipt (independent of 
insurance type) [7, 47], biological differences in cancer subtypes [48], racial/ethnic 
discrimination [49–54], racially/ethnically patterned differences in social capital or social 
support [55], and neighborhood contextual factors [56]. For example, we have reported that 
Black and Hispanic AYAs and AYAs from lower SES neighborhoods with breast cancer 
were less likely to receive radiation after breast conserving surgery [7] or combined-
modality therapy for their Hodgkin lymphoma [14]. Furthermore, biological differences in 
cancer subtypes may be relevant to some cancer sites: Black AYAs are more likely to be 
diagnosed with breast cancer molecular subtypes associated with a shorter prognosis [48], 
and it has been reported that inclusion of molecular subtype and insurance type in survival 
models diminishes the association of Black race/ethnicity with greater risk of death [9]. 
While studies of the effects of racial/ethnic discrimination have not been conducted 
specifically among AYAs, it has been observed that discrimination may impact care 
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utilization (independent of insurance status) [49–51], and that chronic stress due to 
discrimination impacts health outcomes [52–54]. In addition, greater racial/ethnic disparities 
for cancers more amenable to prevention and treatment suggest that differences in access to 
social and economic resources (social capital) likely contribute to residual racial/ethnic 
disparities in cancer survival [55]. Finally, survival disparities for AYAs residing in lower 
SES neighborhoods may be mediated by a number of built and social factors, including (but 
not limited to) walkability, proximity to medical facilities, food availability, cultural norms, 
quality of education, and social support [8, 56]. In order to understand the relative 
contributions of sociodemographic factors to cancer survival, continued research should 
consider specific cancer sites along with available sociodemographic factors, and site-
specific tumor and treatment factors that may impact the associations reported here.
Our study includes a highly diverse and large population of AYAs treated across nearly all 
facilities in California, but is also subject to some limitations not previously discussed. Joint 
associations of sociodemographic factors with survival may differ according to whether 
overall or cancer site-specific survival is considered. For example, among AYAs with thyroid 
cancer, we recently reported higher thyroid cancer-specific survival among Black AYAs, but 
did not observe these associations in analyses of overall survival [8]. Another important 
mediator of associations of race/ethnicity with survival may be individual-level SES, but the 
CCR does not collect individual SES indicators. In addition, the CCR collects insurance type 
at diagnosis or initial treatment, so does not capture changes in insurance status over time. In 
order to have a large enough population size to accommodate stratification of survival 
analyses by cancer type (Table 2) or age group and insurance type (Table 3), we were not 
able to further divide the private/military insurance type category into separate categories of 
private and military insurance. Finally, as with all registry studies, differential 
misclassification of race/ethnicity is possible. However, it has previously been determined 
that the level of agreement between CCR data and self-reported race/ethnicity is excellent 
for Whites and Blacks and intermediate for Hispanics and Asians [21, 57].
5. Conclusions
We found that lacking or having public health insurance was associated with greater risk of 
death for AYAs of all ages and for most cancer sites. Our findings also reveal associations of 
race/ethnicity and neighborhood SES with greater risk of death for AYAs with many types of 
cancer, independent of health insurance type. Survival disparities for Black AYAs compared 
to White AYAs persisted regardless of age group or health insurance type, while disparities 
for Hispanic and Asian/PI AYAs, compared to White AYAs, and for those in lower SES 
neighborhoods were more prominent among younger AYAs and those with private/military 
insurance. Persistent survival disparities according to race/ethnicity and neighborhood SES 
among the privately insured may indicate financial burdens associated with private 
healthcare coverage, and further research is needed to identify whether financial burden and 
other social factors directly contribute to undertreatment, follow-up care, and greater risk of 
death for these groups.
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